Biocept's CEO & President just picked up 36,363 shares

Michael W. Nall, Biocept's CEO & President and a director of the company, recently acquired 36,363 shares of the company. The buys took place at prices ranging from $0.00 to $1.10 per share, on dates ranging from April 30 to October 19, 2016. Nall now owns 74,575 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Nall operates out of San Diego, CA. Some additional info was provided as follows:

As adjusted for the 1-for-3 reverse stock split effected September 27, 2016. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 68,422 fewer shares. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the r eporting person's ownership of 8,000 fewer shares. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 9,524 fewer shares. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 8,898 fewer shares. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept's Sr VP Comm. Operations just declared owning 2,900 shares of Biocept - Feb. 16, 2017
Biocept’S Ceo Issues Letter To Stockholders - Feb. 9, 2017
Bin Li just provided an update on activist position in Biocept - Jan. 27, 2017
Major owner of Biocept just disposed of 1,681,000 shares - Jan. 26, 2017
On November - Jan. 25, 2017

Auto Refresh

Feedback